
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery
Yue Yin, Carlos D. Minacapelli, Veenat Parmar, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Yue Yin, Carlos D. Minacapelli, Veenat Parmar, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Showing 18 citing articles:
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study
Francesco Alessandri, Giancarlo Ceccarelli, Giuseppe Migliara, et al.
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 119-119
Open Access | Times Cited: 15
Francesco Alessandri, Giancarlo Ceccarelli, Giuseppe Migliara, et al.
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 119-119
Open Access | Times Cited: 15
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Mayur Suresh Gawande, N. N. Zade, Praveen Kumar, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Mayur Suresh Gawande, N. N. Zade, Praveen Kumar, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 904-904
Open Access | Times Cited: 14
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 904-904
Open Access | Times Cited: 14
Baseline Gut Microbiome Signatures Correlate with Immunogenicity of SARS-CoV-2 mRNA Vaccines
Lauren Daddi, Yair Dorsett, Tingting Geng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11703-11703
Open Access | Times Cited: 13
Lauren Daddi, Yair Dorsett, Tingting Geng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11703-11703
Open Access | Times Cited: 13
Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection
Kawisara Krasaewes, Romanee Chaiwarith, Nipon Chattipakorn, et al.
Life Sciences (2023) Vol. 332, pp. 122136-122136
Closed Access | Times Cited: 9
Kawisara Krasaewes, Romanee Chaiwarith, Nipon Chattipakorn, et al.
Life Sciences (2023) Vol. 332, pp. 122136-122136
Closed Access | Times Cited: 9
Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
Weijie Xue, Masaki Honda, Taizo Hibi
World Journal of Gastroenterology (2023) Vol. 29, Iss. 15, pp. 2283-2293
Open Access | Times Cited: 8
Weijie Xue, Masaki Honda, Taizo Hibi
World Journal of Gastroenterology (2023) Vol. 29, Iss. 15, pp. 2283-2293
Open Access | Times Cited: 8
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
(2023)
Open Access | Times Cited: 6
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
(2023)
Open Access | Times Cited: 6
Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults
Abigail Armstrong, Daniel B. Horton, Tracy Andrews, et al.
EBioMedicine (2023) Vol. 94, pp. 104731-104731
Open Access | Times Cited: 5
Abigail Armstrong, Daniel B. Horton, Tracy Andrews, et al.
EBioMedicine (2023) Vol. 94, pp. 104731-104731
Open Access | Times Cited: 5
Explore the changes of intestinal flora in patients with coronavirus disease 2019 based on bioinformatics
Gangding Huang, Yanning Mao, Weiwei Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2
Gangding Huang, Yanning Mao, Weiwei Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 2
Identification of Sars-Cov-2 related volatile organic compounds from face masks
Hale Seçi̇lmi̇ş Canbay, Görkem Kısmalı, Fatih Mehmet Emen, et al.
Microchemical Journal (2023) Vol. 197, pp. 109756-109756
Closed Access | Times Cited: 2
Hale Seçi̇lmi̇ş Canbay, Görkem Kısmalı, Fatih Mehmet Emen, et al.
Microchemical Journal (2023) Vol. 197, pp. 109756-109756
Closed Access | Times Cited: 2
The causal relationship between gut microbiota and COVID-19: A two-sample Mendelian randomization analysis
Siyu Tian, Wenhui Huang
Medicine (2024) Vol. 103, Iss. 5, pp. e36493-e36493
Open Access
Siyu Tian, Wenhui Huang
Medicine (2024) Vol. 103, Iss. 5, pp. e36493-e36493
Open Access
TISSUE-SPECIFIC METABOLOMIC REPROGRAMMING DETERMINES THE DISEASE PATHOPHYSIOLOGY OF SARS-COV-2 VARIANTS IN HAMSTER MODEL
Urvinder Kaur Sardarni, Anoop T. Ambikan, Arpan Acharya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Urvinder Kaur Sardarni, Anoop T. Ambikan, Arpan Acharya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The role of intestinal microbiota in physiologic and body compositional changes that accompany CLA-mediated weight loss in obese mice.
Meifan Zhang, Yue S Yin, Karolline S. May, et al.
Molecular Metabolism (2024), pp. 102029-102029
Open Access
Meifan Zhang, Yue S Yin, Karolline S. May, et al.
Molecular Metabolism (2024), pp. 102029-102029
Open Access
Sars-Cov-2 variants mediated tissue-specific metabolomic reprogramming determines the disease pathophysiology in a hamster model
Urvinder Kaur Sardarni, Anoop T. Ambikan, Arpan Acharya, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 914-927
Closed Access
Urvinder Kaur Sardarni, Anoop T. Ambikan, Arpan Acharya, et al.
Brain Behavior and Immunity (2024) Vol. 123, pp. 914-927
Closed Access
Effect of COVID-19 on the Gut Microbiota of Pregnant Women (review)
B. O. Bembeeva, Т. В. Припутневич, Н. В. Долгушина
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 5, pp. 92-98
Open Access
B. O. Bembeeva, Т. В. Припутневич, Н. В. Долгушина
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 5, pp. 92-98
Open Access
Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
Laurence S. C. Lok, Shuvam Sarkar, Chi‐Ming Lam, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access
Laurence S. C. Lok, Shuvam Sarkar, Chi‐Ming Lam, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access
Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
Stefanie Quickert, Andreas Stallmach, Philipp A. Reuken
Deleted Journal (2023) Vol. 18, Iss. 2, pp. 136-142
Open Access
Stefanie Quickert, Andreas Stallmach, Philipp A. Reuken
Deleted Journal (2023) Vol. 18, Iss. 2, pp. 136-142
Open Access